Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: A masked placebo-controlled crossover clinical trial

Veterinary Journal

Volumn 197, Issue 3, 2013, Pages 651-655

  Quimby, J M ^a   Lunn, K F ^b  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Feline; Kidney; Nutrition; Pharmacokinetics; Vomiting

Indexed keywords

ANTIEMETIC AGENT; APPETITE STIMULANT; CREATININE; MIRTAZAPINE; NITROGEN; PHOSPHORUS; PLACEBO; POTASSIUM; UREA;

ANIMAL EXPERIMENT; APPETITE DISORDER; ARTICLE; BLOOD ANALYSIS; CAT DISEASE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; NONHUMAN; NUTRITIONAL HEALTH; PHOSPHATE BLOOD LEVEL; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; POTASSIUM BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; UREA NITROGEN BLOOD LEVEL; VOMITING; WEIGHT GAIN;

FELIDAE;

FELINE; KIDNEY; NUTRITION; PHARMACOKINETICS; VOMITING;

ANIMALS; ANOREXIA; ANTIEMETICS; APPETITE STIMULANTS; CAT DISEASES; CATS; CROSS-OVER STUDIES; FEMALE; MALE; MIANSERIN; RENAL INSUFFICIENCY, CHRONIC; VOMITING;

EID: 84884987542     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2013.05.048     Document Type: Article

References (22)

1. Adetunji B., Basil B., Mathews M., Osinowo T. Mirtazapine-associated dose-dependent and asymptomatic elevation of hepatic enzymes. The Annals of Pharmacotherapy 2007, 41:359.
2. Boyd L.M., Langston C., Thompson K., Zivin K., Imanishi M. Survival in cats with naturally occurring chronic kidney disease (2000-2002). Journal of Veterinary Internal Medicine 2008, 22:1111-1117.
3. Cahill C. Mirtazapine as an antiemetic. Veterinary Forum 2006, 34-36.
4. Chang F.L., Ho S.T., Sheen M.J. Efficacy of mirtazapine in preventing intrathecal morphine-induced nausea and vomiting after orthopaedic surgery. Anaesthesia 2010, 65:1206-1211.
5. Chen C.C., Lin C.S., Ko Y.P., Hung Y.C., Lao H.C., Hsu Y.W. Premedication with mirtazapine reduces preoperative anxiety and postoperative nausea and vomiting. Anesthesia and Analgesia 2008, 106:109-113.
6. Elliott J., Rawlings J.M., Markwell P.J., Barber P.J. Survival of cats with naturally occurring chronic renal failure: Effect of dietary management. Journal of Small Animal Practice 2000, 41:235-242.
7. Jiang S.M., Wu J.H., Jia L. Intervention of mirtazapine on gemcitabine-induced mild cachexia in nude mice with pancreatic carcinoma xenografts. World Journal of Gastroenterology 2012, 18:2867-2871.
8. Kast R.E., Foley K.F. Cancer chemotherapy and cachexia: Mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects. European Journal of Cancer Care 2007, 16:351-354.
9. Kim S.W., Shin I.S., Kim J.M., Kim Y.C., Kim K.S., Kim K.M., Yang S.J., Yoon J.S. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression. Psychiatry and Clinical Neurosciences 2008, 62:75-83.
10. Kopple J.D. Effect of nutrition on morbidity and mortality in maintenance dialysis patients. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation 1994, 24:1002-1009.
11. Laflamme D. Development and validation of a body condition score system for cats: A clinical tool. Feline Practice 1997, 25:13-18.
12. Pae C.U. Low-dose mirtazapine may be successful treatment option for severe nausea and vomiting. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2006, 30:1143-1145.
13. Parker V.J., Freeman L.M. Association between body condition and survival in dogs with acquired chronic kidney disease. Journal of Veterinary Internal Medicine 2011, 25:1306-1311.
14. Plantinga E.A., Everts H., Kastelein A.M., Beynen A.C. Retrospective study of the survival of cats with acquired chronic renal insufficiency offered different commercial diets. Veterinary Record 2005, 157:185-187.
15. Polzin D.J. Chronic kidney disease in small animals. The Veterinary Clinics of North America: Small Animal Practice 2011, 41:15-30.
16. Quimby J.M., Gustafson D.L., Lunn K.F. The pharmacokinetics of mirtazapine in cats with chronic kidney disease and in age-matched control cats. Journal of Veterinary Internal Medicine 2011, 25:985-989.
17. Quimby J.M., Gustafson D.L., Samber B.J., Lunn K.F. Studies on the pharmacokinetics and pharmacodynamics of mirtazapine in healthy young cats. Journal of Veterinary Pharmacology and Therapeutics 2011, 34:388-396.
18. Reynolds C.A., Oyama M.A., Rush J.E., Rozanski E.A., Singletary G.E., Brown D.C., Cunningham S.M., Fox P.R., Bond B., Adin D.B., Williams R.M., MacDonald K.A., et al. Perceptions of quality of life and priorities of owners of cats with heart disease. Journal of Veterinary Internal Medicine 2010, 24:1421-1426.
19. Riechelmann R.P., Burman D., Tannock I.F., Rodin G., Zimmermann C. Phase II trial of mirtazapine for cancer-related cachexia and anorexia. The American Journal of Hospice and Palliative Care 2010, 27:106-110.
20. Ross S.J., Osborne C.A., Kirk C.A., Lowry S.R., Koehler L.A., Polzin D.J. Clinical evaluation of dietary modification for treatment of spontaneous chronic kidney disease in cats. Journal of the American Veterinary Medical Association 2006, 229:949-957.
21. Roudebush P., Polzin D.J., Ross S.J., Towell T.L., Adams L.G., Dru Forrester S. Therapies for feline chronic kidney disease. What is the evidence?. Journal of Feline Medicine and Surgery 2009, 11:195-210.
22. Sanderson B.J. Management of anorexia. Current Veterinary Therapy 2000, 69-74. WB Saunders, Philadelphia, PA, USA. 13th Ed. J. Bonagura (Ed.).